The Claim
Intermittent inhibition of mTORC1 through weekly sirolimus administration may act synergistically with resistance-type exercise to improve muscle performance in older adults by alternately promoting anabolic stimulation via exercise and catabolic reset through autophagy induction, although this proposed mechanism has not been validated in human studies.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a drug called sirolimus once a week might help older adults get stronger when combined with weight training, by giving muscles a break to clean out damaged parts between workouts — but we’re not sure yet if this actually works in people.
See the scientific wording
Intermittent mTORC1 inhibition via weekly sirolimus dosing may synergize with resistance-type exercise to enhance muscle performance in older adults by alternating periods of anabolic stimulation (exercise) and catabolic reset (autophagy induction), though this mechanistic hypothesis remains unproven in humans.
What the research says
1 studyThe study is testing the same idea—giving older adults weekly sirolimus with exercise—but the results aren’t available yet, so we can’t say if it works or not.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.